Published by Josh White on 15th September 2020
(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced the licensing of its sulforaphane stabilisation technology in a number of non-pharmaceutical applications to Juvenescence on Tuesday.
URL: http://www.digitallook.com/dl/news/story/31179392/...